Evidence map›Paper›PMID 34857953›Full record

ArticleNature genetics2021

Large-scale integration of the plasma proteome with genetics and disease.

Egil Ferkingstad, Patrick Sulem, Bjarni A Atlason, Gardar Sveinbjornsson, Magnus I Magnusson, Edda L Styrmisdottir, Kristbjorg Gunnarsdottir, Agnar Helgason, Asmundur Oddsson, Bjarni V Halldorsson and 30 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,088 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,088citing papers in PubMed, 5 pooled it
152.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,088 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,553 citations in OpenAlex.

  1. Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1,028 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 2 institutions in 1 country.

Egil FerkingstaddeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-8090-7988
Patrick SulemdeCODE genetics/Amgen, Inc., Reykjavik, Iceland. patrick.sulem@decode.is.ORCID http://orcid.org/0000-0001-7123-6123
Bjarni A AtlasondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Gardar SveinbjornssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Magnus I MagnussondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Edda L StyrmisdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Kristbjorg GunnarsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Agnar HelgasondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-8545-3767
Asmundur OddssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
Bjarni V HalldorssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-0756-0767
Brynjar O JenssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Florian ZinkdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Gisli H HalldorssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7067-9862
Gisli MassondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Gudny A ArnadottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-6571-423X
Hildigunnur KatrinardottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Kristinn JuliussondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Magnus K MagnussondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-8593-4934
Olafur Th MagnussondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Run FridriksdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Saedis SaevarsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-9392-6184
Sigurjon A GudjonssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Simon N StaceydeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4732-7380
Solvi RognvaldssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4376-3361
Thjodbjorg EiriksdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-1009-7398
Thorunn A OlafsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Valgerdur SteinthorsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-1846-6274
Vinicius TragantedeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-8223-8957
Magnus O UlfarssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-0461-040X
Hreinn StefanssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-9331-6666
Ingileif JonsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-8339-150X
Hilma HolmdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-9517-6636
Thorunn RafnardeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-0491-7046
Pall MelsteddeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Jona SaemundsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Gudmundur L NorddahldeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Sigrun H LunddeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-3806-2296
Daniel F GudbjartssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Kari StefanssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland. kstefans@decode.is.ORCID http://orcid.org/0000-0003-1676-864X
deCODE Genetics (Iceland) · ISReykjavík University · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plasma proteome can help bridge the gap between the genome and diseases. Here we describe genome-wide association studies (GWASs) of plasma protein levels measured with 4,907 aptamers in 35,559 Icelanders. We found 18,084 associations between sequence variants and levels of proteins in plasma (protein quantitative trait loci; pQTL), of which 19% were with rare variants (minor allele frequency (MAF) < 1%). We tested plasma protein levels for association with 373 diseases and other traits and identified 257,490 associations. We integrated pQTL and genetic associations with diseases and other traits and found that 12% of 45,334 lead associations in the GWAS Catalog are with variants in high linkage disequilibrium with pQTL. We identified 938 genes encoding potential drug targets with variants that influence levels of possible biomarkers. Combining proteomics, genomics and transcriptomics, we provide a valuable resource that can be used to improve understanding of disease pathogenesis and to assist with drug discovery and development.

Indexed as

BiomarkersBlood ProteinsDiseaseFemaleGene FrequencyGenetic VariationGenome-Wide Association StudyHumansMaleMiddle AgedProteomeQuantitative Trait LociBiomarkersBlood ProteinsProteome

Identifiers

PMID34857953
OpenAlexW3215894083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.